• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Control of sinus tachycardia as an additional therapy in patients with decompensated heart failure (CONSTATHE-DHF): A randomized, double-blind, placebo-controlled trial.

作者信息

Lofrano-Alves Marco Stephan, Issa Victor Sarli, Biselli Bruno, Chizzola Paulo, Ayub-Ferreira Silvia Moreira, Bocchi Edimar Alcides

机构信息

Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil.

出版信息

J Heart Lung Transplant. 2016 Oct;35(10):1260-1264. doi: 10.1016/j.healun.2016.06.005. Epub 2016 Jun 7.

DOI:10.1016/j.healun.2016.06.005
PMID:27469019
Abstract
摘要

相似文献

1
Control of sinus tachycardia as an additional therapy in patients with decompensated heart failure (CONSTATHE-DHF): A randomized, double-blind, placebo-controlled trial.窦性心动过速控制作为失代偿性心力衰竭患者的附加治疗（CONSTATHE-DHF）：一项随机、双盲、安慰剂对照试验。
J Heart Lung Transplant. 2016 Oct;35(10):1260-1264. doi: 10.1016/j.healun.2016.06.005. Epub 2016 Jun 7.
2
Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.伊伐布雷定治疗不适当窦性心动过速患者的临床疗效：前瞻性、随机、安慰剂对照、双盲、交叉评估。
J Am Coll Cardiol. 2012 Oct 9;60(15):1323-9. doi: 10.1016/j.jacc.2012.06.031. Epub 2012 Sep 12.
3
Ivabradine: appropriate treatment for inappropriate sinus tachycardia.伊伐布雷定：治疗不适当窦性心动过速的合适药物。
Heart Rhythm. 2010 Sep;7(9):1324-5. doi: 10.1016/j.hrthm.2010.06.012. Epub 2010 Jun 9.
4
Conventional management of inappropriate sinus tachycardia.不适当窦性心动过速的传统管理。
J Interv Card Electrophysiol. 2016 Jun;46(1):43-5. doi: 10.1007/s10840-015-0034-0. Epub 2015 Jul 12.
5
Treatment of inappropriate sinus tachycardia with ivabradine.伊伐布雷定治疗不适当窦性心动过速
J Interv Card Electrophysiol. 2016 Jun;46(1):47-53. doi: 10.1007/s10840-015-0066-5. Epub 2015 Oct 14.
6
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.依伐布雷定治疗慢性心力衰竭的疗效评价（SHIFT）：一项随机、安慰剂对照研究
Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1.
7
Inappropriate sinus tachycardia in a heart transplant successfully treated with ivabradine.心脏移植术后不适当窦性心动过速经伊伐布雷定成功治疗
Europace. 2017 Jul 1;19(7):1100. doi: 10.1093/europace/eux038.
8
Inappropriate sinus tachycardia - successful treatment with ivabradine.不适当窦性心动过速——伊伐布雷定静脉注射治疗成功。
Kardiol Pol. 2010 Aug;68(8):935-7.
9
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.心率作为慢性心力衰竭的危险因素（SHIFT）：一项随机安慰剂对照试验中心率与结局的关系。
Lancet. 2010 Sep 11;376(9744):886-94. doi: 10.1016/S0140-6736(10)61259-7.
10
Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: A pooled analysis of prospective studies.不适当窦性心动过速-伊伐布雷定的症状和心率降低：前瞻性研究的汇总分析。
Heart Rhythm. 2018 Feb;15(2):240-247. doi: 10.1016/j.hrthm.2017.10.004. Epub 2017 Oct 7.

引用本文的文献

1
Efficacy and Safety of Ivabradine for Patients With Acute Heart Failure: Meta-Analysis of Randomized Controlled Trials.伊伐布雷定治疗急性心力衰竭有效性和安全性的 Meta 分析：随机对照试验研究
Ann Noninvasive Electrocardiol. 2024 Nov;29(6):e70012. doi: 10.1111/anec.70012.
2
Ivabradine in patients with heart failure: a systematic literature review.伊伐布雷定用于心力衰竭患者：一项系统文献综述。
J Mark Access Health Policy. 2023 Oct 4;11(1):2262073. doi: 10.1080/20016689.2023.2262073. eCollection 2023.
3
Successful treatment with ivabradine in a β-blocker-refractory patient with acute decompensated heart failure with reduced ejection fraction.
伊伐布雷定成功治疗一名射血分数降低的急性失代偿性心力衰竭且对β受体阻滞剂难治的患者。
Clin Case Rep. 2023 Mar 4;11(3):e6890. doi: 10.1002/ccr3.6890. eCollection 2023 Mar.
4
Initiating ivabradine during hospitalization in patients with acute heart failure: A real-world experience in China.急性心力衰竭患者住院期间起始使用伊伐布雷定：中国真实世界经验。
Clin Cardiol. 2022 Sep;45(9):928-935. doi: 10.1002/clc.23880. Epub 2022 Jul 23.
5
Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis.依伐布雷定联合心力衰竭常规治疗的系统评价：荟萃分析和试验序贯分析。
BMJ Evid Based Med. 2022 Aug;27(4):224-234. doi: 10.1136/bmjebm-2021-111724. Epub 2021 Nov 17.
6
Ivabradine as adjuvant treatment for chronic heart failure.伊伐布雷定作为慢性心力衰竭的辅助治疗
Cochrane Database Syst Rev. 2020 Nov 4;11(11):CD013004. doi: 10.1002/14651858.CD013004.pub2.
7
Hemodynamic effects of ivabradine use in combination with intravenous inotropic therapy in advanced heart failure.伊伐布雷定联合静脉内正性肌力治疗在晚期心力衰竭中的血液动力学效应。
Heart Fail Rev. 2021 Mar;26(2):355-361. doi: 10.1007/s10741-020-10029-x. Epub 2020 Sep 30.
8
Effect of Ivabradine on Left Ventricular Diastolic Function, Exercise Tolerance and Quality of Life in Patients With Heart Failure: A Systemic Review and Meta-Analysis of Randomized Controlled Trials.伊伐布雷定对心力衰竭患者左心室舒张功能、运动耐量及生活质量的影响：一项随机对照试验的系统评价和荟萃分析
Cardiol Res. 2020 Feb;11(1):40-49. doi: 10.14740/cr958. Epub 2020 Jan 26.
9
Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial.伊伐布雷定治疗恰加斯病心力衰竭的安全性和疗效：SHIFT 试验的事后分析。
ESC Heart Fail. 2018 Jun;5(3):249-256. doi: 10.1002/ehf2.12240. Epub 2017 Dec 20.